COVID-19 Testing

Testing is an important component to slowing the spread of disease in a community. To find local COVID-19 testing, click here.

C19Test



COVIDtests.gov (Get Free at-Home COVID-19 Tests)  






Kent City Health Department has at-Home personal use COVID-19 testing kits available while supplies last. These tests provide rapid results to allow for quarantine/isolation measures if applicable. Be advised that results do not provide documented proof of testing and may not meet requirements needed for travel, employment etc. 

New COVID-19 Test to Treat       Initiative and Locator Tool

HHS/ASPR Program Provides Individuals with Faster, Easier Access to 
Life-saving COVID-19 Testing and Treatment in the Same Location


A new federal  Test to Treat  program gives fast and easy ways to get lifesaving treatment for COVID-19. In this program, individuals can get tested at Test to Treat sites. If they test positive and treatments are appropriate for them, they can get a prescription from a healthcare provider and have the prescription filled all in one location. People can also bring test results obtained from a home testing kit to Test to Treat sites and get evaluated by a healthcare provider for treatment. These one-stop Test to Treat sites are available nationwide at hundreds of pharmacy-based clinics and Health Resources and Services Administration (HRSA)-supported federally qualified health centers (FQHCs).

In addition, the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) launched a new COVID-19 Test to Treat Locator. People can use this web-based tool to find Test to Treat sites near them. 

Oral antiviral pills from Merck (Lagevrio) and Pfizer (Paxlovid) are available at Test to Treat sites. The Test to Treat program does not change existing requirements for qualified healthcare providers to write the prescriptions for these medications. In addition, people can continue to get tested and treated by their own healthcare providers, who can prescribe these oral antivirals to eligible patients. Patients can pick up those prescriptions wherever oral antivirals are distributed. 

If these oral antivirals are inappropriate for patients, additional COVID-19 therapeutic options outside the Test to Treat program are available. The National Institutes of Health (NIH) has developed and regularly updates Treatment Guidelines to help guide healthcare providers caring for patients with COVID-19. 

To learn more, visit: